Stock 688179 SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Shanghai Aladdin Biochemical Technology Co.,Ltd.

Equities

688179

CNE100005XD0

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
16.62 CNY -2.41% Intraday chart for Shanghai Aladdin Biochemical Technology Co.,Ltd. +3.68% -13.26%
Apr. 29 Shanghai Aladdin Biochemical Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 19 Shanghai Aladdin Biochemical Technology Co.,Ltd. agreed to acquire 51% stake in Shanghai Yuanye Biotechnology Co., Ltd. for CNY 180 million from Cui Yuanyuan and Tan Xiaoyong. CI

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • The company's profit outlook over the next few years is a strong asset.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • The group's activity appears highly profitable thanks to its outperforming net margins.

Weaknesses

  • The company appears highly valued given the size of its balance sheet.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.

Ratings chart - Surperformance

Sector: Biotechnology & Medical Research

1st Jan change Capi. Investor Rating ESG Refinitiv
SHANGHAI ALADDIN BIOCHEMICAL TECHNOLOGY CO.,LTD. Stock Shanghai Aladdin Biochemical Technology Co.,Ltd.
-13.26% 456M -
MODERNA, INC. Stock Moderna, Inc.
+17.96% 44.96B
B-
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.17% 42.65B
B
LONZA GROUP AG Stock Lonza Group AG
+48.77% 41.85B
A
CELLTRION, INC. Stock Celltrion, Inc.
-4.27% 29.04B
C
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.42% 26.08B
B-
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.39% 19.03B
B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.86% 12.75B
B+
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.29% 12.06B
C+
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.50% 11.75B
C+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-
  1. Stock Market
  2. Equities
  3. 688179 Stock
  4. Ratings Shanghai Aladdin Biochemical Technology Co.,Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW